Logo image of SMG

SCOTTS MIRACLE-GRO CO (SMG) Stock Fundamental Analysis

USA - NYSE:SMG - US8101861065 - Common Stock

60.48 USD
-0.27 (-0.44%)
Last: 9/15/2025, 4:10:03 PM
60.48 USD
0 (0%)
After Hours: 9/15/2025, 4:10:03 PM
Fundamental Rating

4

Taking everything into account, SMG scores 4 out of 10 in our fundamental rating. SMG was compared to 83 industry peers in the Chemicals industry. SMG has a medium profitability rating, but doesn't score so well on its financial health evaluation. SMG is not valued too expensively and it also shows a decent growth rate. Finally SMG also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SMG had positive earnings in the past year.
In the past year SMG had a positive cash flow from operations.
In multiple years SMG reported negative net income over the last 5 years.
SMG had a positive operating cash flow in 4 of the past 5 years.
SMG Yearly Net Income VS EBIT VS OCF VS FCFSMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

With a Return On Assets value of 1.72%, SMG perfoms like the industry average, outperforming 57.83% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 14.61%, SMG belongs to the top of the industry, outperforming 93.98% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SMG is above the industry average of 6.34%.
The last Return On Invested Capital (14.61%) for SMG is above the 3 year average (10.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.72%
ROE N/A
ROIC 14.61%
ROA(3y)-7.51%
ROA(5y)-0.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.63%
ROIC(5y)13.54%
SMG Yearly ROA, ROE, ROICSMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

SMG's Profit Margin of 1.54% is in line compared to the rest of the industry. SMG outperforms 55.42% of its industry peers.
Looking at the Operating Margin, with a value of 12.32%, SMG is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
SMG's Operating Margin has declined in the last couple of years.
The Gross Margin of SMG (29.77%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SMG has declined.
Industry RankSector Rank
OM 12.32%
PM (TTM) 1.54%
GM 29.77%
OM growth 3Y-13.17%
OM growth 5Y-5.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.65%
GM growth 5Y-4.15%
SMG Yearly Profit, Operating, Gross MarginsSMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

SMG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SMG has been increased compared to 1 year ago.
SMG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SMG is higher compared to a year ago.
SMG Yearly Shares OutstandingSMG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SMG Yearly Total Debt VS Total AssetsSMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

SMG has an Altman-Z score of 2.62. This is not the best score and indicates that SMG is in the grey zone with still only limited risk for bankruptcy at the moment.
SMG's Altman-Z score of 2.62 is fine compared to the rest of the industry. SMG outperforms 73.49% of its industry peers.
SMG has a debt to FCF ratio of 8.95. This is a slightly negative value and a sign of low solvency as SMG would need 8.95 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 8.95, SMG is doing good in the industry, outperforming 69.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.95
Altman-Z 2.62
ROIC/WACC1.63
WACC8.97%
SMG Yearly LT Debt VS Equity VS FCFSMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

SMG has a Current Ratio of 1.61. This is a normal value and indicates that SMG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.61, SMG is not doing good in the industry: 67.47% of the companies in the same industry are doing better.
SMG has a Quick Ratio of 1.61. This is a bad value and indicates that SMG is not financially healthy enough and could expect problems in meeting its short term obligations.
SMG has a worse Quick ratio (0.93) than 71.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.93
SMG Yearly Current Assets VS Current LiabilitesSMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

SMG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.33%, which is quite impressive.
SMG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.83% yearly.
SMG shows a decrease in Revenue. In the last year, the revenue decreased by -2.05%.
Measured over the past years, SMG shows a small growth in Revenue. The Revenue has been growing by 2.40% on average per year.
EPS 1Y (TTM)89.33%
EPS 3Y-37.53%
EPS 5Y-12.83%
EPS Q2Q%12.12%
Revenue 1Y (TTM)-2.05%
Revenue growth 3Y-10.32%
Revenue growth 5Y2.4%
Sales Q2Q%-1.18%

3.2 Future

SMG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.93% yearly.
Based on estimates for the next years, SMG will show a small growth in Revenue. The Revenue will grow by 0.46% on average per year.
EPS Next Y66.66%
EPS Next 2Y40.39%
EPS Next 3Y32.55%
EPS Next 5Y24.93%
Revenue Next Year-3.72%
Revenue Next 2Y-0.93%
Revenue Next 3Y0.16%
Revenue Next 5Y0.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMG Yearly Revenue VS EstimatesSMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
SMG Yearly EPS VS EstimatesSMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.95, which indicates a rather expensive current valuation of SMG.
60.24% of the companies in the same industry are more expensive than SMG, based on the Price/Earnings ratio.
SMG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.70 indicates a correct valuation of SMG.
Based on the Price/Forward Earnings ratio, SMG is valued a bit cheaper than the industry average as 60.24% of the companies are valued more expensively.
SMG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.95
Fwd PE 13.7
SMG Price Earnings VS Forward Price EarningsSMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SMG's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SMG indicates a rather cheap valuation: SMG is cheaper than 81.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.28
EV/EBITDA 11.28
SMG Per share dataSMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

SMG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SMG's earnings are expected to grow with 32.55% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y40.39%
EPS Next 3Y32.55%

7

5. Dividend

5.1 Amount

SMG has a Yearly Dividend Yield of 4.28%, which is a nice return.
SMG's Dividend Yield is rather good when compared to the industry average which is at 3.43. SMG pays more dividend than 85.54% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, SMG pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

The dividend of SMG has a limited annual growth rate of 3.51%.
SMG has been paying a dividend for at least 10 years, so it has a reliable track record.
SMG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)3.51%
Div Incr Years0
Div Non Decr Years3
SMG Yearly Dividends per shareSMG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

SMG pays out 289.64% of its income as dividend. This is not a sustainable payout ratio.
SMG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP289.64%
EPS Next 2Y40.39%
EPS Next 3Y32.55%
SMG Yearly Income VS Free CF VS DividendSMG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M
SMG Dividend Payout.SMG Dividend Payout, showing the Payout Ratio.SMG Dividend Payout.PayoutRetained Earnings

SCOTTS MIRACLE-GRO CO

NYSE:SMG (9/15/2025, 4:10:03 PM)

After market: 60.48 0 (0%)

60.48

-0.27 (-0.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners74.67%
Inst Owner Change4.87%
Ins Owners0.55%
Ins Owner Change-0.3%
Market Cap3.49B
Analysts76.92
Price Target77.18 (27.61%)
Short Float %8.7%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend2.66
Dividend Growth(5Y)3.51%
DP289.64%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-22 2025-08-22 (0.66)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.29%
Min EPS beat(2)-0.27%
Max EPS beat(2)12.85%
EPS beat(4)2
Avg EPS beat(4)6.18%
Min EPS beat(4)-16.32%
Max EPS beat(4)28.45%
EPS beat(8)6
Avg EPS beat(8)7.66%
EPS beat(12)8
Avg EPS beat(12)6.19%
EPS beat(16)11
Avg EPS beat(16)4.76%
Revenue beat(2)0
Avg Revenue beat(2)-5.07%
Min Revenue beat(2)-6.02%
Max Revenue beat(2)-4.12%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)5.18%
Revenue beat(8)4
Avg Revenue beat(8)1.01%
Revenue beat(12)5
Avg Revenue beat(12)-0.37%
Revenue beat(16)6
Avg Revenue beat(16)-0.19%
PT rev (1m)0%
PT rev (3m)12.1%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)-8.84%
EPS NY rev (1m)4.21%
EPS NY rev (3m)6.74%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)1.44%
Revenue NY rev (1m)-0.78%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 17.95
Fwd PE 13.7
P/S 1.02
P/FCF 14.28
P/OCF 11.06
P/B N/A
P/tB N/A
EV/EBITDA 11.28
EPS(TTM)3.37
EY5.57%
EPS(NY)4.41
Fwd EY7.3%
FCF(TTM)4.24
FCFY7%
OCF(TTM)5.47
OCFY9.04%
SpS59.59
BVpS-2.96
TBVpS-14.28
PEG (NY)0.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.72%
ROE N/A
ROCE 18.49%
ROIC 14.61%
ROICexc 14.94%
ROICexgc 21.1%
OM 12.32%
PM (TTM) 1.54%
GM 29.77%
FCFM 7.11%
ROA(3y)-7.51%
ROA(5y)-0.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.63%
ROIC(5y)13.54%
ROICexc(3y)10.91%
ROICexc(5y)13.96%
ROICexgc(3y)15.3%
ROICexgc(5y)22.83%
ROCE(3y)13.46%
ROCE(5y)17.14%
ROICexcg growth 3Y-10.58%
ROICexcg growth 5Y-6.7%
ROICexc growth 3Y-7.68%
ROICexc growth 5Y0%
OM growth 3Y-13.17%
OM growth 5Y-5.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.65%
GM growth 5Y-4.15%
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.95
Debt/EBITDA 4.27
Cap/Depr 92.94%
Cap/Sales 2.07%
Interest Coverage 3.11
Cash Conversion 63.09%
Profit Quality 460.64%
Current Ratio 1.61
Quick Ratio 0.93
Altman-Z 2.62
F-Score8
WACC8.97%
ROIC/WACC1.63
Cap/Depr(3y)104.14%
Cap/Depr(5y)98.52%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.33%
EPS 3Y-37.53%
EPS 5Y-12.83%
EPS Q2Q%12.12%
EPS Next Y66.66%
EPS Next 2Y40.39%
EPS Next 3Y32.55%
EPS Next 5Y24.93%
Revenue 1Y (TTM)-2.05%
Revenue growth 3Y-10.32%
Revenue growth 5Y2.4%
Sales Q2Q%-1.18%
Revenue Next Year-3.72%
Revenue Next 2Y-0.93%
Revenue Next 3Y0.16%
Revenue Next 5Y0.46%
EBIT growth 1Y23.95%
EBIT growth 3Y-22.13%
EBIT growth 5Y-3.01%
EBIT Next Year58.86%
EBIT Next 3Y23.69%
EBIT Next 5Y17.18%
FCF growth 1Y-46.59%
FCF growth 3Y52.48%
FCF growth 5Y25.91%
OCF growth 1Y-42.21%
OCF growth 3Y34.97%
OCF growth 5Y24.1%